2024 年至 2031 年血管攝影導管市場（依產品、應用及地區劃分）

2024 年至 2031 年血管攝影導管市場評估

由於多種因素，血管造影導管市場的需求正在快速成長。心血管疾病（主要是冠狀動脈疾病和中風）的發生率不斷上升，促使對診斷和介入程序的需求增加。這些導管在可視化血管和執行血管成形術和支架置入術等微創手術中發揮關鍵作用。預計2024年市場規模將超過13.7億美元，2031年將達到約24.2億美元。

導管技術的進步，包括材料的改進、直徑的減少和成像能力的增強，使得導管更有效、侵入性更小，從而進一步推動了需求。人口老化日益加劇，使人們更容易患心血管疾病，從而促進了市場擴張。由於對具有成本效益且高效的血管造影導管的需求不斷增加，預計 2024 年至 2031 年期間市場複合年增長率將達到 7.38%。

血管攝影導管市場定義/概述

血管造影導管是一種專門的醫療設備，用於將造影劑注入血管動脈，以便在血管造影過程中在 X 光影像上看到造影劑。這些導管有助於觀察心臟動脈、靜脈和心室的結構和功能，使臨床醫生能夠檢測和治療多種心血管疾病，包括阻塞、動脈瘤和先天性異常。血管攝影導管是細而柔軟的管子，透過動脈（最常見的是股動脈或橈動脈）插入並使用影像技術引導到所需區域。

血管攝影導管主要用於診斷和介入性心臟病學的冠狀動脈、週邊和腦血管造影。這些導管也用於血管成形術、支架植入術和栓塞術等治療程序。隨著影像技術的發展以及更靈活、生物相容性和可操縱性的導管，血管造影導管的未來可能會包括更精確和更少侵入性的程序。由於全球心血管疾病發生率不斷上升及影像引導手術的增多，血管造影導管的需求預計持續上升，這可能是由於機器人輔助導管手術的發展及即時影像技術的進步。

導管設計技術的進步會推動血管攝影導管市場的發展嗎？

導管設計的進步，尤其是微導管和可操縱導管等創新，正在推動血管攝影導管市場的發展。這些技術進步將使複雜血管網路中的導航更加精確，從而提高血管造影程序的準確性和安全性。FDA 在 2020 年批准了 43 種新的心血管設備，其中許多涉及導管技術，顯示這些先進技術的利用率有所提高。

老年人口可能會刺激血管攝影導管市場的發展。隨著世界人口老化，冠狀動脈疾病和動脈粥狀硬化等心血管疾病的盛行率不斷增加，這些疾病通常可以透過治療性血管攝影進行檢測和治療。根據聯合國預測，到 2050 年，65 歲及以上人口預計將從 2019 年的 7.03 億增加一倍達到 15 億。老年人口的大幅增加預計將刺激對心血管檢測和治療的需求，從而加速血管造影導管市場的擴張。

高昂的手術費用會阻礙血管攝影導管市場的成長嗎？

預計血管造影導管市場的成長將受到血管攝影手術高成本的影響。這些價格可能會限制獲得這些程序的機會並減少總需求，特別是在醫療資源有限的中低收入國家。醫院和醫療機構在投資先進的血管攝影設備和導管時也可能面臨成本限制。即使在已開發國家，患者的費用（特別是在保險覆蓋有限的系統中）也可能導致醫療程序的延遲或縮減，從而限制市場成長。

風險和併發症可能會影響血管攝影導管市場的成長。由於這些導管用於關鍵的心血管手術，感染、過敏反應、血管損傷和造影劑誘發腎臟病的風險可能會引起患者和醫療保健專業人員的擔憂。隨著監管審查的加強和醫療保健專業人員轉向替代診斷方法，人們對這些風險的認識可能會提高，並限制市場擴張。此外，安全問題將影響市場動態，推動對更安全解決方案的需求，同時增加成本，這可能會阻礙廣泛採用。

目錄

第 1 章全球血管攝影導管市場簡介

• 市場概況
• 調查範圍
• 先決條件

第 2 章 執行摘要

第3章 VERIFIED MARKET RESEARCH研究方法

• 數據挖掘
• 驗證
• 一次資料
• 數據源列表

第4章 血管攝影導管全球市場展望

• 概述
• 市場動態
• 促進因素
• 阻礙因素
• 機會
• 波特的五力模型
• 價值鏈分析

第 5 章全球血管攝影導管市場（按產品）

• 刻劃球囊導管
• 常規導管
• DEB導管
• 切割球囊導管

第6章 全球血管攝影導管市場（依應用）

• 影像中心
• 醫院
• 診所

第7章 全球血管攝影導管市場（按地區）

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 德國
• 英國
• 法國
• 歐洲其他地區
• 亞太地區
• 中國
• 日本
• 印度
• 亞太其他地區
• 世界其他地區
• 拉丁美洲
• 中東/非洲

第 8 章全球血管攝影導管市場：競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

第10章 附錄

• 相關報導

Angiography Catheters Market Valuation - 2024-2031

The angiography catheters market is experiencing a surge in demand due to several factors. Primarily, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and stroke, has led to a greater need for diagnostic and interventional procedures. These catheters play a crucial role in visualizing blood vessels and performing minimally invasive treatments like angioplasty and stent placement. The market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of aroundUSD 2.42 Billion by 2031.

Advancements in catheter technology, including improved materials, smaller diameters, and enhanced imaging capabilities, have made them more effective and less invasive, further driving demand. The growing aging population, which is more susceptible to cardiovascular diseases, is contributing to the market's expansion. The rising demand for cost-effective and efficient angiography catheters is enabling the market to grow at aCAGR of 7.38% from 2024 to 2031.

Angiography Catheters Market: Definition/ Overview

Angiography catheters are specialized medical devices that inject contrast media into blood arteries to make them visible on X-ray imaging during angiography operations. These catheters aid in seeing the structure and function of the heart's arteries, veins, and chambers, allowing clinicians to detect and treat a wide range of cardiovascular diseases including blockages, aneurysms, and congenital anomalies. Angiography catheters are flexible, thin tubes that are put via an artery, most commonly the femoral or radial artery, and directed to the desired region using imaging techniques.

Angiography catheters are primarily used in diagnostic and interventional cardiology to perform coronary, peripheral, and cerebral angiograms. These catheters are also used in therapeutic procedures like angioplasty, stent implantation, and embolization. With developments in imaging technology and the development of more flexible, biocompatible, and steerable catheters, the future of angiography catheters will involve more precise and least invasive procedures. The growing global prevalence of cardiovascular illnesses, combined with an increase in image-guided therapies, predicts that demand for angiography catheters will continue to climb, possibly due to developments in robotic-assisted catheterization and increased real-time imaging technology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Advancement in Technology of Catheter Design Fuel the Angiography Catheters Market?

Advancements in catheter design, notably innovations such as micro-catheters and steerable catheters, are propelling the angiography catheter market. These technical advancements enable more precise navigation in complex vascular networks, improving the accuracy and safety of angiography treatments. The FDA's approval of 43 new cardiovascular devices in 2020, many of which involve catheter technology, demonstrates the rising use of these advanced technologies.

The elderly population is likely to fuel the angiography catheter market. As the world population ages, the prevalence of cardiovascular disorders such as coronary artery disease and atherosclerosis rises, which are frequently detected and treated via angiography treatments. According to the United Nations, the number of individuals aged 65 and more is predicted to double from 703 million in 2019 to 1.5 billion by 2050. This considerable increase in the older population will fuel demand for cardiovascular tests and therapies, accelerating the expansion of the angiography catheters market.

Will the High-Cost Associated with Procedures Hamper the Growth of the Angiography Catheters Market?

The high cost of angiography operations is anticipated to have an impact on market growth for angiography catheters. These prices can limit access to such procedures, particularly in low- and middle-income countries with limited healthcare resources, lowering total demand. Hospitals and healthcare facilities may also face cost constraints when investing in sophisticated angiography equipment and catheters. Patient expenses, even in industrialized countries, may result in delayed or curtailed procedures, especially in systems with limited insurance coverage, limiting market growth.

Risks and complications can have an impact on the growth of the angiography catheter market. These catheters are utilized in crucial cardiovascular procedures, and any dangers, including infections, allergic reactions, blood vessel damage, or contrast-induced nephropathy, might cause concern among both patients and healthcare personnel. Increased awareness of these dangers may restrict market expansion as regulatory scrutiny intensifies and healthcare professionals turn to alternate diagnostic methods. Furthermore, safety concerns may influence market dynamics, pushing demand for safer solutions while potentially increasing costs, and discouraging widespread use.

Category-Wise Acumens

Will the Integration of Drug-Eluting Technology Drive the Drug-Eluting Balloon Catheters Segments for the Angiography Catheters Market?

Drug-

eluting balloon catheter segments dominate the angiography catheters market. The integration of drug-eluting technology is projected to propel the drug-eluting balloon catheters sector of the angiography catheters market. Drug-eluting balloon catheters direct therapeutic substances to the target site, lowering restenosis and enhancing patient outcomes in vascular procedures. This technology, together with increased rates of cardiovascular disease and a shift toward minimally invasive procedures, is expected to increase demand and expand the market for these advanced catheters.

The prevalence of cardiovascular illnesses is projected to drive the expansion of the drug-eluting balloon (DEB) catheter segment in the angiography catheter market. As cardiovascular disorders such as coronary artery disease and peripheral artery disease become more common, owing to aging populations and lifestyle choices, there is a greater need for better treatment alternatives. DEB catheters, which release medicines to prevent arterial re-narrowing (restenosis) during angioplasty, are a targeted and successful treatment that reduces the need for stent insertion. This makes them an appealing alternative for healthcare professionals, accelerating their adoption in response to the growing burden of cardiovascular disease.

Will the High Volume of Patients Requiring Cardiovascular Procedures Accelerate the Hospital's Segment for the Angiography Catheters Market?

Hospital's segment fastest leading in the angiography catheters market. The large volume of patients requiring cardiovascular operations is expected to boost the angiography catheters market in the hospital segment. As the prevalence of cardiovascular illnesses rises worldwide, there is an increasing demand for diagnostic and interventional techniques that rely primarily on angiography catheters. These devices are critical for diagnosing and treating coronary artery disease and peripheral vascular disease. Furthermore, advances in catheter technology and increased healthcare investments in cardiovascular care are propelling this market forward, as hospitals strive to improve diagnostic accuracy and treatment efficacy.

The availability of advanced medical equipment and qualified workers is expected to drive the hospital segment's growth in the angiography catheter market. This expansion is being driven by the rising need for precise diagnostic and therapeutic treatments that necessitate high-quality angiography catheters. Advanced equipment improves the accuracy and efficiency of these treatments, while trained clinicians make the best use of the technology, resulting in better patient results. Furthermore, the increased prevalence of cardiovascular disorders, as well as the necessity for sophisticated imaging procedures to manage these conditions, are driving up demand for advanced angiography catheters in hospitals.

Country/Region-wise Acumens

Will Improvement in Health Infrastructure in North America Boost the Angiography Catheters Market?

North America is dominating in angiography catheters market thanks to its improved health infrastructure. The growing progress of healthcare infrastructure will drive the North American angiography catheters market. North America excels in this market due to its advanced healthcare infrastructure, large patient population, and high frequency of cardiovascular disorders. With cardiovascular disease expected to affect more than 40% of the US population by 2030, the demand for sophisticated diagnostic tools such as angiography catheters will increase. Furthermore, the strong presence of major industry players and ongoing advancements will drive market expansion in the region.

The North American market for angiography catheters is predicted to rise due to an aging population. According to the United States Census Bureau, the baby boomer group will account for 73 million of the senior population by 2030. Because cardiovascular disease risk rises with age, this demographic trend is projected to boost the demand for diagnostic equipment such as angiography catheters. As a result, North America's expanding elderly population will significantly drive market demand, as more individuals will need cardiovascular evaluations and treatments.

Will Increasing Awareness of Cardiovascular Health Lead the Asia Pacific's Angiography Catheters Market?

Asia Pacific is rapidly growing in the angiography catheters market owing to its increased awareness of cardiovascular health. The increasing frequency of cardiovascular diseases (CVDs), which are the main cause of death worldwide, particularly in Asia, accounts for 35% of all deaths. As people become more conscious of their cardiovascular health, they seek diagnostic and interventional procedures, which increases the demand for angiography catheters. Furthermore, the region's aging population and expanding healthcare facilities drive up demand, positioning the market for significant development.

Government initiatives are propelling the Asia-Pacific angiography catheters market. Efforts to enhance healthcare access and affordability are driving market growth, as demonstrated in China, where coronary angiography operations increased by about 50% between 2015 and 2019, owing to rising healthcare costs and an aging population. Similarly, India's rising prevalence of cardiovascular illnesses, which is expected to exceed 103 million cases by 2030, and Japan's consistent increase in percutaneous coronary interventions (PCI) drive demand for angiography catheters, generating significant potential possibilities in the area.

Competitive Landscape

The angiography catheters market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include:

• Medtronic
• Boston Scientific Corporation
• Terumo Medical Corporation
• Merit Medical Systems
• AngioDynamics
• Cardinal Health
• Braun Melsungen AG
• Becton
• Dickinson and Company

Latest Developments

• In February 2022, Teleflex received Food and Drug Administration clearance for an expanded indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions.
• In October 2022, The HELIOSTAR Balloon Ablation Catheter is indicated for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria beginning when combined with a suitable multi-channel RF generator.
• In July 2021, Philips announced the first minimally-invasive heart procedure using its real-time 3D intracardiac echocardiography catheter

TABLE OF CONTENTS

1. Introduction of Global Angiography Catheters Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Angiography Catheters Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Angiography Catheters Market, By Product

• Scoring Balloon Catheters
• Conventional Catheters
• DEB Catheters
• Cutting Balloon Catheters

6. Global Angiography Catheters Market, By Application

• ASCs
• Hospitals
• Clinics

7. Global Angiography Catheters Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Angiography Catheters Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

10. Appendix

• Related Reports